Comparing Cyclophosphamide vs Mycophenolate Mofetil
| Cyclophosphamide | Mycophenolate mofetil |
|
|---|
| Cyclophosphamide | Mycophenolate mofetil |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Breast Cancer, Acute Lymphocytic Leukemia, Acute Nonlymphocytic Leukemia, Brain Tumor, Bullous Pemphigoid, Burkitt Lymphoma, Cervical Cancer, Chronic Lymphocytic Leukemia, Chronic... View more |
Prescription only
Prescribed for Autoimmune Hepatitis, Bullous Pemphigoid, Organ Transplant - Rejection Prophylaxis, Crohn's Disease, Cogan's Syndrome, Dermatomyositis, Evan's Syndrome, Graft Versus Host Disease, High... View more |
Related suggestions Rheumatoid Arthritis
Organ Transplant, Rejection Prophylaxis
|
|||||||||||||||
| More about Cyclophosphamide | More about Mycophenolate mofetil | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Cyclophosphamide has an average rating of 8.4 out of 10 from a total of 12 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 8% reported a negative effect. |
Mycophenolate mofetil has an average rating of 7.9 out of 10 from a total of 60 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 12% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Cyclophosphamide side effects |
View all Mycophenolate mofetil side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
Lower cost generic |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Cyclophosphamide prices |
View all Mycophenolate mofetil prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Frindovyx | CellCept, Myhibbin | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
6.5 hours |
18 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 409 drugs are known to interact with Cyclophosphamide:
|
A total of 351 drugs are known to interact with Mycophenolate mofetil:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
November 16, 1959 |
May 03, 1995 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
|
|
||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Imbruvica
Imbruvica (ibrutinib) is used to treat chronic lymphocytic leukemia (CLL), small lymphocytic ...
Jaypirca
Jaypirca (pirtobrutinib) is a cancer medicine used to treat types of CLL, SLL, and MCL. Includes ...
Saphnelo
Saphnelo is used for moderate to severe SLE (lupus) for adults who are also receiving other lupus ...
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.